.jpg?format=webp&quality=80&width=3840)
External beam radiotherapy (EBRT) is important in treating localized prostate cancer. Current image-guided radiotherapy (IGRT) techniques allow for more accurate and precise radiation treatment delivery by imaging before each fraction. This technique could increase the therapeutic window of EBRT by improving normal tissue sparing due to margin reduction and more accurate target dose delivery. This is particularly promising for prostate cancer, with its biology lending itself to ultra-hypofractionation, reducing radiotherapy treatment to as little as five fractions. This article discusses these unique opportunities and the potential future benefits of MRgRT in prostate cancer treatment.
Like
Save
Share